Pregnancy in women with systemic lupus erythematosus (SLE)

European Journal of Internal Medicine

Volumn 32, Issue , 2016, Pages 7-12

  Moroni, Gabriella ^a   Ponticelli, Claudio ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID; PHOSPHOLIPID ANTIBODY; RITUXIMAB; TACROLIMUS; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; IMMUNOSUPPRESSIVE AGENT;

FEMALE; FETUS OUTCOME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PERSONAL EXPERIENCE; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ABORTION, SPONTANEOUS; ANTIPHOSPHOLIPID SYNDROME; CESAREAN SECTION; CONGENITAL ABNORMALITIES; DISEASE COURSE; IMMUNOLOGY; LOW BIRTH WEIGHT; LUPUS ERYTHEMATOSUS, SYSTEMIC; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY COMPLICATIONS; PREPREGNANCY CARE; STATISTICS AND NUMERICAL DATA;

ABORTION, SPONTANEOUS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; CESAREAN SECTION; CONGENITAL ABNORMALITIES; DISEASE PROGRESSION; FEMALE; HEPARIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, LOW BIRTH WEIGHT; LUPUS ERYTHEMATOSUS, SYSTEMIC; OBSTETRIC LABOR, PREMATURE; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84973617025     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2016.04.005     Document Type: Review

References (105)

1. M.E. Clowse, M. Jamison, E. Myers, and A.H. James A national study of the complications of lupus in pregnancy Am. J. Obstet. Gynecol. 199 2 2008 127.e1 127.e6
2. A. Smyth, G.H. Oliveira, B.D. Lahr, K.R. Bailey, S.M. Norby, and V.D. Garovic A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis Clin. J. Am. Soc. Nephrol. 5 11 2010 2060 2068
3. D.L. Huong, B. Wechsler, D. Vauthier-Brouzes, H. Beaufils, G. Lefebvre, and J.C. Piette Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre Ann. Rheum. Dis. 60 6 2001 599 604
4. L. Soubassi, D. Haidopoulos, M. Sindos, A. Pilalis, D. Chaniotis, E. Diakomanolis, and et al. Pregnancy outcome in women with pre-existing lupus nephritis J. Obstet. Gynaecol. 24 6 2004 630 634
5. K. Bramham, B.J. Hunt, S. Bewley, S. Germain, I. Calatayud, M.A. Khamashta, and et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis J. Rheumatol. 38 9 2011 1906 1913
6. D.D. Gladman, A. Tandon, D. Ibañez, and M.B. Urowitz The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications J. Rheumatol. 37 4 2010 754 758
7. M.A. Saavedra, C. Cruz-Reyes, O. Vera-Lastra, G.T. Romero, P. Cruz-Cruz, R. Arias-Flores, and et al. Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy Clin. Rheumatol. 31 5 2012 813 819
8. G. Stojan, and A.N. Baer Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management Expert. Rev. Clin. Immunol. 8 5 2012 439 453
9. J. Cortés-Hernández, J. Ordi-Ros, F. Paredes, M. Casellas, F. Castillo, and M. Vilardell-Tarres Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies Rheumatology (Oxford) 41 2002 643 650
10. M.J. Yang, C.Y. Chen, W.H. Chang, J.Y. Tseng, and C.C. Yeh Pregnancy outcome of systemic lupus erythematosus in relation to lupus activity before and during pregnancy J. Chin. Med. Assoc. 78 4 2015 235 240
11. J.H. Koh, H.S. Ko, J. Lee, S.M. Jung, S.K. Kwok, J.H. Ju, and et al. Pregnancy and patients with preexisting lupus nephritis: 15 years of experience at a single center in Korea Lupus 24 7 2015 764 772
12. M. Ostensen, and M. Clowse Pathogenesis of pregnancy complications in systemic lupus erythematosus Curr. Opin. Rheumatol. 25 5 2013 591 596
13. V.D. Garovic, and P. August Preeclampsia and the future risk of hypertension: the pregnant evidence Curr. Hypertens. Rep. 15 2 2013 114 121
14. T.L. Weissgerber, S.T. Turner, K.R. Bailey, T.H. Mosley Jr., S.L. Kardia, H.J. Wiste, and et al. Hypertension in pregnancy is a risk factor for peripheral arterial disease decades after pregnancy Atherosclerosis 229 1 2013 212 216
15. C.A. Clark, K.A. Spitzer, and Laskin CA Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period J. Rheumatol. 32 9 2005 1709 1712
16. M.E. Clowse, L.S. Magder, F. Witter, and M. Petri The impact of increased lupus activity on obstetric outcomes Arthritis Rheum. 52 2 2005 514 521
17. G. Moroni, S. Quaglini, G. Banfi, M. Caloni, S. Finazzi, G. Ambroso, and et al. Pregnancy in lupus nephritis Am. J. Kidney Dis. 40 4 2002 713 720
18. E. Imbasciati, A. Tincani, G. Gregorini, A. Doria, G. Moroni, G. Cabiddu, and et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome Nephrol. Dial. Transplant. 24 2 2009 519 525
19. S.J. Wagner, I. Craici, D. Reed, S. Norby, K. Bailey, H.J. Wiste, and et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis Lupus 18 4 2009 342 347
20. M.E. Clowse, L.S. Magder, and M. Petri The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus J. Rheumatol. 38 6 2011 1012 1016
21. D.L. Yetman, and W.H. Kutteh Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies Fertil. Steril. 66 1996 540 546
22. R.S. Rai, K. Clifford, H. Cohen, and L. Regan High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies Hum. Reprod. 10 1995 3301 3304
23. O. Valenti, F.A. Di Prima, E. Renda, M. Faraci, E. Hyseni, R. De Domenico, and et al. Fetal cardiac function during the first trimester of pregnancy J. Prenat. Med. 5 3 2011 59 62
24. M.J. Simchen, M. Dulitzki, G. Rofe, H. Shani, P. Langevitz, E. Schiff, and et al. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome Acta Obstet. Gynecol. Scand. 90 12 2011 1428 1433
25. G. Carvalheiras, R. Faria, J. Braga, and C. Vasconcelos Fetal outcome in autoimmune diseases Autoimmun. Rev. 11 6-7 2012 A520 A530
26. S. De Carolis, A. Botta, S. Santucci, S. Salvi, S. Moresi, E. Di Pasquo, and et al. Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome Lupus 21 7 2012 776 778
27. A.D. Askanase, Friedman DM, J. Copel, Dische MR, A. Dubin, Starc TJ, and et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies Lupus 11 2002 145 151
28. A.N. Baer, F.R. Witter, and M. Petri Lupus and pregnancy Obstet. Gynecol. Surv. 66 10 2011 639 653
29. D.D. Gladman, A. Tandon, D. Ibanez, and M.B. Urowitz The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications J. Rheumatol. 37 2010 754 758
30. J. Lv, W. Wang, and Y. Li Clinical outcomes and predictors of fetal and maternal consequences of pregnancy in lupus nephritis Int. Urol. Nephrol. 47 2015 1379 1385
31. F. Carmona, J. Font, I. Moga, I. Làzaro, R. Cervera, V. Pac, and et al. Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases Am. J. Reprod. Immunol. 53 4 2005 182 188
32. E. Borella, A. Lojacono, M. Gatto, L. Andreoli, M. Taglietti, L. Iaccarino, and et al. Predictors of maternal and fetal complications in SLE patients: a prospective study Immunol. Res. 60 2-3 2014 170 176
33. H. Yang, H. Liu, D. Xu, L. Zhao, Q. Wang, X. Leng, and et al. Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares - a case control study PLoS One 9 8 2014 e104375
34. M.D. Lockshin, E. Reinitz, M.L. Druzin, M. Murrman, and D. Estes Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy Am. J. Med. 77 5 1984 893 898
35. M.B. Urowitz, D.D. Gladman, V.T. Farewell, J. Stewart, and J. McDonald Lupus and pregnancy studies Arthritis Rheum. 36 10 1993 1392 1397
36. M. Petri, D. Howard, and J. Repke Frequency of lupus flare in pregnancy. The Hopkins lupus pregnancy center experience Arthritis Rheum. 34 12 1991 1538 1545
37. G. Ruiz-Irastorza, F. Lima, J. Alves, M.A. Khamashta, J. Simpson, G.R. Hughes, and et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies Br. J. Rheumatol. 35 2 1996 133 138
38. C. Ponticelli, and G. Moroni Flares in lupus nephritis: incidence, impact on renal survival and management Lupus 7 9 1998 635 638
39. G. Moroni, and C. Ponticelli Rapidly progressive crescentic glomerulonephritis: early treatment is a must Autoimmun. Rev. 13 7 2014 723 729
40. T.G. Wegmann, H. Lin, L. Guilbert, and T.R. Mosmann Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol. Today 14 7 1993 353 356
41. S. Saito, A. Nakashima, T. Shima, and M. Ito Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy Am. J. Reprod. Immunol. 63 6 2010 601 610
42. V.R. Aluvihare, M. Kallikourdis, and A.G. Betz Regulatory T cells mediate maternal tolerance to the fetus Nat. Immunol. 5 2004 266 271
43. V. Dardalhon, A.C. Anderson, J. Karman, L. Apetoh, R. Chandwaskar, D.H. Lee, and et al. Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b + Ly-6G + myeloid cells J. Immunol. 185 3 2010 1383 1392
44. M. Meggyes, E. Miko, B. Polgar, B. Bogar, B. Farkas, Z. Illes, and et al. Peripheral blood TIM-3 positive NK and CD8 + T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy PLoS One 9 3 2014 e92371
45. E. Miko, M. Meggyes, B. Bogar, N. Schmitz, A. Barakonyi, A. Varnagy, and et al. Involvement of galectin-9/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia PLoS One 8 8 2013 e71811
46. A.M. Borzychowski, B.A. Croy, W.L. Chan, C.W.G. Redman, and I.L. Sargent Changes in systemic type 1 and type 2 immunity in normal pregnancy and preeclampsia may be mediated by natural killer cells Eur. J. Immunol. 35 10 2005 3054 3063
47. P. Luppi, C. Haluszczak, M. Trucco, and J.A. DeLoia Normal pregnancy is associated with peripheral leukocyte activation Am. J. Reprod. Immunol. 47 2 2002 72 81
48. M.M. Faas, R.B. Donker, M.G. van Pampus, A.M. Huls, J. Salomons, P. de Vos, and et al. Plasma of pregnant and preeclamptic women activates monocytes in vitro Am. J. Obstet. Gynecol. 199 1 2008 84.e1 84.e8
49. L.J. Jara, G. Medina, P. Cruz-Dominguez, C. Navarro, O. Vera-Lastra, and M.A. Saavedra Risk factors of systemic lupus erythematosus flares during pregnancy Immunol. Res. 60 2-3 2014 184 192
50. K. Sarter, C. Janko, S. André, L.E. Muñoz, C. Schorn, S. Winkler, and et al. Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus Glycobiology 23 1 2013 12 22
51. C. Janko, S. André, L.E. Munoz, J.P. Briand, C. Schorn, S. Winkler, and et al. Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndrome Lupus 21 7 2012 781 783
52. P.E. Love, and S.A. Santoro Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance Ann. Intern. Med. 112 9 1990 682 698
53. R. Cervera, Piette JC, J. Font, Khamashta MA, Y. Shoenfeld, Camps MT, and et al. Euro-Phospholipid Project Group Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Arthritis Rheum. 46 4 2002 1019 1027
54. V. Pengo, A. Banzato, E. Bison, G. Denas, S. Padayattil Jose, and A. Ruffatti Antiphospholipid syndrome: critical analysis of the diagnostic path Lupus 19 4 2010 428 431
55. M.L. Bertolaccini, O. Amengual, L. Andreoli, T. Atsumi, C.B. Chighizola, R. Forastiero, and et al. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends Autoimmun. Rev. 13 9 2014 917 930
56. A. Ruffatti, M. Tonello, M.S. Visentin, A. Bontadi, A. Hoxha, S. De Carolis, and et al. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study Rheumatology (Oxford) 50 9 2011 1684 1689
57. Thuong D. Le Thi, N. Tieulié, N. Costedoat, M.R. Andreu, B. Wechsler, D. Vauthier-Brouzes, and et al. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women Ann. Rheum. Dis. 64 2 2005 273 278
58. G.R. de Jesus, N. Agmon-Levin, C.A. Andrade, L. Andreoli, C.B. Chighizola, T.F. Porter, and et al. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome Autoimmun Rev. 13 8 2014 795 813
59. R.A. Levy, Dos Santos FC, de Jesús GR, and de Jesús NR Antiphospholipid antibodies and antiphospholipid syndrome during pregnancy: diagnostic concepts Front. Immunol. 6 2015 205
60. A. Lateef, and M. Petri Management of pregnancy in systemic lupus erythematosus Nat. Rev. Rheumatol. 8 12 2012 710 718
61. C. Ponticelli, and G. Moroni Immunosuppression in pregnant women with systemic lupus erythematosus Expert. Rev. Clin. Immunol. 11 5 2015 549 552
62. P. von Dadelszen, M.P. Ornstein, S.B. Bull, A.G. Logan, G. Koren, and L.A. Magee Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis Lancet 355 9198 2000 87 92
63. W.O. Cooper, S. Hernandez-Diaz, P.G. Arbogast, J.A. Dudley, S. Dyer, P.S. Gideon, and et al. Major congenital malformations after first-trimester exposure to ACE inhibitors N. Engl. J. Med. 354 23 2006 2443 2451
64. J.E. Polifka Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence Birth Defects Res. 94 2012 576 598
65. C.J. Day, G.W. Lipkin, and C.O. Savage Lupus nephritis and pregnancy in the 21st century Nephrol. Dial. Transplant. 24 2 2009 344 347
66. A.K. Singh Lupus nephritis and the anti-phospholipid antibody syndrome in pregnancy Kidney Int. 58 5 2000 2240 2254
67. R.G. Farquharson, S. Quenby, and M. Greaves Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment Obstet. Gynecol. 100 3 2002 408 413
68. A. Ruffatti, E. Salvan, T. Del Ross, M. Gerosa, L. Andreoli, A. Maina, and et al. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study Thromb. Haemost. 112 4 2014 727 735
69. O. Amengual, D. Fujita, E. Ota, L. Carmona, K. Oku, M. Sugiura-Ogasawara, and et al. Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review Lupus Mar 25 2015 [pii: 0961203315578765]
70. J.H. Rand, X.X. Wu, A.S. Quinn, P.P. Chen, J.J. Hathcock, and Taatjes DJ Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers Blood 112 5 2008 1687 1695
71. M. Gerosa, P.L. Meroni, and R. Cimaz Safety considerations when prescribing immunosuppression medication to pregnant women Expert Opin. Drug Saf. 13 12 2014 1591 1599
72. M. Ostensen, M. Khamashta, M. Lockshin, A. Parke, A. Brucato, H. Carp, and et al. Anti-inflammatory and immunosuppressive drugs and reproduction Arthritis Res. Ther. 8 2006 209
73. D. Erkan, C.L. Aguiar, D. Andrade, H. Cohen, M.J. Cuadrado, A. Danowski, and et al. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends Autoimmun. Rev. 13 6 2014 685 696
74. A.M. Bay Bjørn, V. Ehrenstein, H.H. Hundborg, E.A. Nohr, H.T. Sørensen, and M. Nørgaard Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring Am. J. Ther. 21 2 2014 73 80
75. C.J. McKinlay, C.A. Crowther, P. Middleton, and J.E. Harding Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane systematic review Am. J. Obstet. Gynecol. 206 3 2012 187 194
76. M.E. Clowse Pregnancy in women with SLE D.J. Wallace, B.H. Hahn, Dubois' Lupus Erythematosus and Related Syndromes 8th ed. 2013 Elsevier, Saunders Philadelphia 455 463
77. G. Moroni, and C. Ponticelli The risk of pregnancy in patients with lupus nephritis J. Nephrol. 16 2 2003 161 167
78. M.E. Clowse, L. Magder, and M. Petri Cyclophosphamide for lupus during pregnancy Lupus 14 8 2005 593 597
79. G. Lannes, F.R. Elias, B. Cunha, N. Jesus, E.M. Klumb, E.M. Albuquerque, and et al. Successful pregnancy after cyclophosphamide therapy for lupus nephritis Arch. Gynecol. Obstet. 283 Suppl. 1 2011 61 65
80. R.G. Palmer, C.G. Doré, and A.M.M. Denman Cyclophosphamide induces more chromosome damage than chlorambucil in patients with connective tisuue diseases Q. J. Med. 59 1986 395 400
81. L.H. Goldstein, G. Dolinsky, R. Greenberg, C. Schaefer, R. Cohen-Kerem, O. Diav-Citrin, and et al. Pregnancy outcome of women exposed to azathioprine during pregnancy Birth Defects Res. A Clin. Mol. Teratol. 79 10 2007 696 701
82. V.T. Armenti, J.S. Radomski, M.J. Moritz, W.J. Gaughan, L.Z. Philips, C.H. McGrory, and et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation Clin. Transpl. 121-30 2002
83. M. Hoeltzenbein, E. Elefant, T. Vial, V. Finkel-Pekarsky, S. Stephens, M. Clementi, and et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services Am. J. Med. Genet. A 158A 3 2012 588 596
84. M.T. Anderka, A.E. Lin, D.N. Abuelo, A.A. Mitchell, and S.A. Rasmussen Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature Am. J. Med. Genet. A 149A 6 2009 1241 1248
85. H. Al Maimouni, D.D. Gladman, D. Ibañez, and M.B. Urowitz Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes Arthritis Care Res. (Hoboken) 66 12 2014 1905 1909
86. H. Kim, J.C. Jeong, J. Yang, W.S. Yang, C. Ahn, D.J. Han, and et al. The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation Clin. Transpl. 29 2 2015 142 148
87. B. Bar Oz, R. Hackman, T. Einarson, and G. Koren Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis Transplantation 71 8 2001 1051 1055
88. D.B. McKay, and M.A. Josephson Pregnancies in recipients of solid organs N. Engl. J. Med. 354 2006 1281 1293
89. C.D. Chambers, Z.M. Tutunku, D. Johnson, and K.L. Jones Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data Arthritis Res. Ther. 8 2006 215 225
90. S. Hou Pregnancy in renal transplant recipients Adv. Chronic Kidney Dis. 20 3 2013 253 259
91. K. Bramham, G. Chusney, J. Lee, L. Lightstone, and C. Nelson-Piercy Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants Clin. J. Am. Soc. Nephrol. 8 4 2013 563 567
92. A. Alsuwaida Successful management of systemic lupus erythematosus nephritis flare-up during pregnancy with tacrolimus Mod. Rheumatol. 21 1 2011 73 75
93. P. Webster, A. Wardle, K. Bramham, L. Webster, C. Nelson-Piercy, and L. Lightstone Tacrolimus is an effective treatment for lupus nephritis in pregnancy Lupus 23 11 2014 1192 1196
94. N. Sass, J.L. Sato, T.A. Facca, V.A. Gomes, H.T. Silva Júnior, M.R. Mesquita, and et al. [219-POS]: Tacrolimus as the first choice of immunosuppressive therapy in kidney transplantation pregnant did not reduce significantly maternal and perinatal risks. A preliminary analysis Pregnancy Hypertens. 5 1 2015 110 111
95. R.L. Brent Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child Teratology 63 2001 106 112
96. M. Cassina, D.L. Johnson, L.K. Robinson, S.R. Braddock, R. Xu, J.L. Jimenez, and et al. Organization of Teratology Information Specialists Collaborative Research Group. Pregnancy outcome in women exposed to leflunomide before or during pregnancy Arthritis Rheum. 64 7 2012 2085 2094
97. J. Ramasethu Methotrexate and misoprostol teratogenicity: further expansion of the clinical manifestations Am. J. Med. Genet. A 155A 7 2011 1723 1728
98. M. Ojeda-Uribe, N. Afif, E. Dahan, L. Sparsa, C. Haby, J. Sibilia, and et al. Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases Clin. Rheumatol. 32 5 2013 695 700
99. P.K. Mandal, T.K. Dolai, B. Bagchi, M.K. Ghosh, S. Bose, and M. Bhattacharyya B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen Indian J. Pediatr. 81 10 2014 1092 1094
100. K.L. Hyrich, and Verstappen SM Biologic therapies and pregnancy: the story so far Rheumatology (Oxford) 53 8 2014 1377 1385
101. H. Landy, M. Powell, D. Hill, A. Eudy, and M. Petri Belimumab pregnancy registry: prospective cohort study of pregnancy outcomes Obstet. Gynecol. 123 Suppl. 1 2014 62S
102. O. Diav-Citrin, S. Blyakhman, S. Shechtman, and A. Ornoy Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study Reprod. Toxicol. 39 2013 58 62
103. N. Costedoat-Chalumeau, Z. Amoura, P. Duhaut, D.L. Huong, D. Sebbough, B. Wechsler, and et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group Arthritis Rheum. 48 2003 3207 3211
104. M.E. Clowse, L. Magder, F. Witter, and M. Petri Hydroxychloroquine in lupus pregnancy Arthritis Rheum. 54 11 2006 3640 3647
105. P.M. Izmirly, N. Costedoat-Chalumeau, C.N. Pisoni, M.A. Khamashta, M.Y. Kim, A. Saxena, and et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus Circulation 126 1 2012 76 82